Micafungin: experimental therapy of fungal infections in animal models;Micafungina en el tratamiento de la infección fúngica en modelos animales

Revista Iberoamericana de Micologia

Volumn 26, Issue 1, 2009, Pages 42-48

  Javier Pastor, Francisco ^a   Guarro, Josep ^a  

^a FACULTAT DE MEDICINA I CIÈNCIES DE LA SALUT   (Spain)

Author keywords

Animal models; Aspergillosis; Candidiasis; Experimental infection; Micafungin

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANIDULAFUNGIN; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; MICAFUNGIN; VORICONAZOLE;

ANIMAL MODEL; ANTIFUNGAL SUSCEPTIBILITY; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BLASTOMYCOSIS; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDIASIS; DRUG EFFICACY; FUNGAL STRAIN; FUNGICIDAL ACTIVITY; FUSARIOSIS; IN VITRO STUDY; LUNG ASPERGILLOSIS; MEDLINE; MYCOSIS; NONHUMAN; REVIEW; TRICHOSPORON ASAHII; TRICHOSPORONOSIS;

ANIMALS; ANTIFUNGAL AGENTS; ASPERGILLOSIS; CANDIDIASIS; DRUG EVALUATION, PRECLINICAL; ECHINOCANDINS; FUSARIUM; IMMUNOCOMPROMISED HOST; LIPOPEPTIDES; MICE; MUCORMYCOSIS; MYCOSES; RABBITS; RATS; RHIZOPUS; SACCHAROMYCETALES; TRICHOSPORON;

ANIMALIA; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CANDIDA GLABRATA;

EID: 67650741934     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1130-1406(09)70007-5     Document Type: Review

References (23)

1. Andes D.R., Diekema D.J., Pfaller M.A., Marchillo K., and Bohrmueller J. In vivo pharmacodynamic target investigation for micafungin against Candida albicans and C. glabrata in a neutropenic murine candidiasis model. Antimicrob Agents Chemother 52 (2008) 3497-3503
2. Clemons K.V., Espiritu M., Parmar R., and Stevens D.A. Comparative efficacies of conventional amphotericin B, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against esperimental murine central nervous system aspergillosis. Antimicrob Agents Chemother 49 (2005) 4867-4875
3. Clemons K.V., Parmar R., Martinez M., and Stevens D.A. Efficacy of Abelcet alone, or in combination therapy, against experimental central nervous system aspergillosis. J Antimicrob Chemother 58 (2006) 466-469
4. Clemons K.V., Sobel R.A., and Stevens D.A. Toxicity of LY303366, an echinocandin antifungal, in mice pretreated with glucocorticoids. Antimicrob Agents Chemother 44 (2000) 378-381
5. Clemons K.V., and Stevens D.A. Efficacy of micafungin alone or in combination against experimental pulmonary aspergillosis. Med Mycol 44 (2006) 69-73
6. Denning D.W. Echinocandin antifungal drugs. Lancet 362 (2003) 1142-1151
7. phox-/- mouse model of chronic granulomatous disease. Antimicrob Agents Chemother 50 (2006) 422-427
8. Graybill J.R. The role of murine models in the development of antifungal therapy for systemic mycoses. Drug Resist Updat 3 (2000) 364-383
9. Gumbo T., Drusano G.L., Liu W., Kulawy R.W., Fregeau C., Hsu V., and Louie A. Once-weekly micafungin therapy is as effective as daily therapy for disseminated candidiasis in mice with persistent neutropenia. Antimicrob Agents Chemother 51 (2007) 968-974
10. Hiraoka T., Kaji Y., Wakabayashi T., Nanbu P.N., Okamoto F., and Oshika T. Comparison of micafungin and fluconazol for experimental Candida keratitis in rabbits. Cornea 26 (2007) 336-342
11. Hope W.W., Mickiene D., Petraitis V., Petraitiene R., Kelaher A.M., Hughes J.E., Cotton M.P., Bacher J., Keirns J.J., Buell D., Heresi G., Benjamin Jr. D.K., Groll A.H., Drusano G.L., and Walsh T.J. The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates. J Infect Dis. 197 (2008) 163-171
12. Ibrahim A.S., Gebremariam T., Fu Y., Edwards Jr. J.E., and Spellberg B. Combination echinocandin-polyene treatment of murine mucormycosis. Antimicrob Agents Chemother 52 (2008) 1556-1558
13. Lewis R.E., Albert N.D., and Kontoyiannis D.P. Efficacy of single-dose of liposomal amphotericin B or micafungin prophylaxis in a neutropenic murine model of invasive pulmonary aspergillosis. Antimicrob Agents Chemother 52 (2008) 4178-4180
14. Lewis R.E., Albert N.D., and Kontoyiannis D.P. Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosis. J Antimicrob Chemother 61 (2008) 1140-1144
15. Mariné M., Serena C., Fernández-Torres B., Pastor F.J., and Guarro J. Activities of flucytosine, fluconazole, amphotericin B, and micafungin in a murine model of disseminated infection by Candida glabrata. Antimicrob Agents Chemother 49 (2005) 4757-4759
16. Mariné M., Serena C., Pastor F.J., and Guarro J. Combined antifungal therapy in a murine infection by Candida glabrata. J Antimicrob Chemother 58 (2006) 1295-1298
17. Ninomiya M., Mikamo H., Tanaka K., Watanabe K., and Tamaya T. Efficacy of micafungin against deep-seated candidiasis in cyclophosphamide-induced immunosuppressed mice. J Antimicrob Chemother 55 (2005) 587-590
18. Nuevos principios activos con dictamen positivo para su autorización. Micafungina sódica. Mycamine. Agencia Española de Medicamentos y productos sanitarios 2008. Disponible en: http://www.agemed.es/actividad/notaMensual/febrero2008/nota_medicamentos.htm.
19. Olson J.A., Adler-Moore J.P., Smith P.J., and Proffitt R.T. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal anfotericin B with caspofungin or micafungin. Antimicrob Agents Chemother 49 (2005) 4895-4902
20. Ruiz-Cendoya M., Mariné M., and Guarro J. Combined therapy in treatment of murine infection by Fusarium solani. J Antimicrob Chemother 62 (2008) 543-546
21. Serena C., Pastor F.J., Gilgado F., Mayayo E., and Guarro J. Efficacy of micafungin in combination with other drugs in a murine model of disseminated trichosporonosis. Antimicrob Agents Chemother 49 (2005) 497-502
22. Serena C., Rodríguez M.M., Mariné M., Pastor F.J., and Guarro J. Combined therapies in a murine model of blastoschizomycosis. Antimicrob Agents Chemother 51 (2007) 2608-2610
23. Serena C., Rodríguez M.M., Mariné M., Pastor F.J., and Guarro J. Micafungin combined with fluconazole, an effective therapy for murine blastoschizomycosis. J Antimicrob Chemother 61 (2008) 877-879